S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
AMC   40.01 (+0.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
AMC   40.01 (+0.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
AMC   40.01 (+0.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
AMC   40.01 (+0.08%)
NASDAQ:NXGN

NextGen Healthcare Stock Forecast, Price & News

$14.53
-0.19 (-1.29 %)
(As of 09/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$14.51
$14.84
50-Day Range
$14.53
$16.29
52-Week Range
$11.80
$23.80
Volume162,645 shs
Average Volume331,664 shs
Market Capitalization$978.33 million
P/E Ratio72.65
Dividend YieldN/A
Beta1.15
30 days | 90 days | 365 days | Advanced Chart
Receive NXGN News and Ratings via Email

Sign-up to receive the latest news and ratings for NextGen Healthcare and its competitors with MarketBeat's FREE daily newsletter.


NextGen Healthcare logo

About NextGen Healthcare

NextGen Healthcare, Inc. engages in the development and marketing of electronic health records, practice management, revenue cycle management, and interoperability solutions. It offers the core; automation and workflow; analytics, population health, and patient engagement, interoperability; managed services; professional services; and client service and support. The company was founded by Sheldon Razin in 1974 and is headquartered in Atlanta, GA.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

2.30 out of 5 stars

Medical Sector

243rd out of 1,351 stocks

Computer Integrated Systems Design Industry

14th out of 39 stocks

Analyst Opinion: 3.1Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











NextGen Healthcare (NASDAQ:NXGN) Frequently Asked Questions

Is NextGen Healthcare a buy right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for NextGen Healthcare in the last twelve months. There are currently 2 sell ratings, 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" NextGen Healthcare stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NXGN, but not buy additional shares or sell existing shares.
View analyst ratings for NextGen Healthcare
or view top-rated stocks.

What stocks does MarketBeat like better than NextGen Healthcare?

Wall Street analysts have given NextGen Healthcare a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but NextGen Healthcare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is NextGen Healthcare's next earnings date?

NextGen Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, October 28th 2021.
View our earnings forecast for NextGen Healthcare
.

How were NextGen Healthcare's earnings last quarter?

NextGen Healthcare, Inc. (NASDAQ:NXGN) announced its earnings results on Thursday, July, 29th. The company reported $0.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.14 by $0.11. The company had revenue of $146.08 million for the quarter, compared to the consensus estimate of $139.97 million. NextGen Healthcare had a net margin of 2.31% and a trailing twelve-month return on equity of 12.73%.
View NextGen Healthcare's earnings history
.

How has NextGen Healthcare's stock been impacted by Coronavirus (COVID-19)?

NextGen Healthcare's stock was trading at $11.01 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NXGN shares have increased by 32.0% and is now trading at $14.53.
View which stocks have been most impacted by COVID-19
.

What guidance has NextGen Healthcare issued on next quarter's earnings?

NextGen Healthcare issued an update on its FY 2022 earnings guidance on Thursday, August, 5th. The company provided earnings per share guidance of $0.890-$0.950 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.910. The company issued revenue guidance of $576 million-$586 million, compared to the consensus revenue estimate of $579.64 million.

What price target have analysts set for NXGN?

8 equities research analysts have issued 1-year price targets for NextGen Healthcare's stock. Their forecasts range from $18.00 to $23.00. On average, they expect NextGen Healthcare's stock price to reach $20.71 in the next twelve months. This suggests a possible upside of 42.6% from the stock's current price.
View analysts' price targets for NextGen Healthcare
or view top-rated stocks among Wall Street analysts.

Who are NextGen Healthcare's key executives?

NextGen Healthcare's management team includes the following people:
  • L. Allen Plunk, Executive Vice President-Operations
  • James R. Arnold, Chief Financial Officer & Executive Vice President
  • David A. Metcalfe, Chief Technology Officer & Executive VP
  • Betty Rabinowitz, Chief Medical Officer
  • John S. Beck, Chief Solutions Officer & Executive Vice President

What is Rusty Frantz's approval rating as NextGen Healthcare's CEO?

248 employees have rated NextGen Healthcare CEO Rusty Frantz on Glassdoor.com. Rusty Frantz has an approval rating of 72% among NextGen Healthcare's employees.

What other stocks do shareholders of NextGen Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NextGen Healthcare investors own include Altria Group (MO), Verizon Communications (VZ), Exxon Mobil (XOM), Best Buy (BBY), Enbridge (ENB), Enterprise Products Partners (EPD), Huntington Bancshares (HBAN), Netflix (NFLX), Tapestry (TPR) and Twitter (TWTR).

What is NextGen Healthcare's stock symbol?

NextGen Healthcare trades on the NASDAQ under the ticker symbol "NXGN."

Who are NextGen Healthcare's major shareholders?

NextGen Healthcare's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (13.87%), Brown Capital Management LLC (11.51%), Vanguard Group Inc. (8.89%), Dimensional Fund Advisors LP (3.61%), State Street Corp (2.73%) and Kennedy Capital Management Inc. (2.20%). Company insiders that own NextGen Healthcare stock include Craig A Barbarosh, David Ahmadzai, George H Bristol, James Robert Jr Arnold, Jeffrey D Linton, Jeffrey H Margolis, John R Frantz, Lance Rosenzweig, Mitchell Waters and Sean Brynjelsen.
View institutional ownership trends for NextGen Healthcare
.

Which institutional investors are selling NextGen Healthcare stock?

NXGN stock was sold by a variety of institutional investors in the last quarter, including Invesco Ltd., Brown Capital Management LLC, Russell Investments Group Ltd., First Trust Advisors LP, BlackRock Inc., Smith Graham & Co. Investment Advisors LP, AXA S.A., and Bank of America Corp DE. Company insiders that have sold NextGen Healthcare company stock in the last year include Craig A Barbarosh, David Ahmadzai, George H Bristol, John R Frantz, Lance Rosenzweig, and Mitchell Waters.
View insider buying and selling activity for NextGen Healthcare
or view top insider-selling stocks.

Which institutional investors are buying NextGen Healthcare stock?

NXGN stock was acquired by a variety of institutional investors in the last quarter, including Paradigm Capital Management Inc. NY, JPMorgan Chase & Co., Millennium Management LLC, Point72 Asset Management L.P., Wade G W & Inc., Renaissance Technologies LLC, Bridgewater Associates LP, and Charles Schwab Investment Management Inc.. Company insiders that have bought NextGen Healthcare stock in the last two years include James Robert Jr Arnold, Jeffrey D Linton, Jeffrey H Margolis, and Sean Brynjelsen.
View insider buying and selling activity for NextGen Healthcare
or or view top insider-buying stocks.

How do I buy shares of NextGen Healthcare?

Shares of NXGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NextGen Healthcare's stock price today?

One share of NXGN stock can currently be purchased for approximately $14.53.

How much money does NextGen Healthcare make?

NextGen Healthcare has a market capitalization of $978.33 million and generates $556.82 million in revenue each year. The company earns $9.52 million in net income (profit) each year or $0.72 on an earnings per share basis.

How many employees does NextGen Healthcare have?

NextGen Healthcare employs 2,564 workers across the globe.

What is NextGen Healthcare's official website?

The official website for NextGen Healthcare is www.nextgen.com.

Where are NextGen Healthcare's headquarters?

NextGen Healthcare is headquartered at 18111 Von Karman Avenue Suite 800, Irvine CA, 92612.

How can I contact NextGen Healthcare?

NextGen Healthcare's mailing address is 18111 Von Karman Avenue Suite 800, Irvine CA, 92612. The company can be reached via phone at (404) 467-1500 or via email at [email protected].


This page was last updated on 9/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.